Drug Costs Concept

subject area of

• A Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline  Journal Articles
• A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets  Journal Articles
• A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs  Journal Articles
• A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study  Journal Articles
• A SECOND LOOK AT PHARMACEUTICAL SPENDING AS DETERMINANTS OF HEALTH OUTCOMES IN CANADA  Journal Articles
• A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder.  Journal Articles
• A pilot study on cost-related medication nonadherence in Ontario.  Journal Articles
• A population-based analysis of incentive payments to primary care physicians for the care of patients with complex disease  Journal Articles
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Journal Articles
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Journal Articles
• A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results  Journal Articles
• A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.  Conferences
• A reappraisal of generic bisphosphonates in osteoporosis  Journal Articles
• A review and economic evaluation of bronchodilator delivery methods in hospitalized patients  Journal Articles
• An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma  Journal Articles
• An estimate of the cost of conducting phase II trials in lung cancer  Journal Articles
• Andexanet alfa for the treatment of hemorrhage  Journal Articles
• Antidepressant use among elderly patients.  Journal Articles
• Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.  Journal Articles
• Antihypertensive treatment – navigating between cost, compliance and complications  Journal Articles
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data  Journal Articles
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Journal Articles
• Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey  Journal Articles
• Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD Countries.  Journal Articles
• Botulinum Toxin Type A and Acute Drug Costs in Migraine with Triptan Overuse  Journal Articles
• Calculating the Affordability of Antiretrovirals in St Lucia  Journal Articles
• Canada’s Amendment to Patented Drug Price Regulation  Journal Articles
• Canadian Economic Evaluation of Budesonide‐Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma  Journal Articles
• Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.  Journal Articles
• Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.  Journal Articles
• Chemotherapy waste reduction through shelf-life extension.  Journal Articles
• Combination Therapy to Prevent Cardiovascular Disease  Journal Articles
• Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges  Journal Articles
• Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs  Journal Articles
• Cost Implications of the Use of Ramipril in High-Risk Patients Based on the Heart Outcomes Prevention Evaluation (HOPE) Study  Journal Articles
• Cost effectiveness analysis of population-based serology screening and ¹³C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model  Journal Articles
• Cost implications of the use of basal insulin glargine in people with early dysglycemia: The ORIGIN trial  Journal Articles
• Cost prediction models for the comparison of two groups  Journal Articles
• Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease  Journal Articles
• Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis  Journal Articles
• Cost-Utility Analysis of Low-Dose Pioglitazone in a Population With Prediabetes and a History of Stroke or Transient Ischemic Attack.  Journal Articles
• Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective  Journal Articles
• Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK  Journal Articles
• Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.  Journal Articles
• Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer  Journal Articles
• Costs of Remission and Recovery Using Family Therapy for Adolescent Anorexia Nervosa: A Descriptive Report  Journal Articles
• Costs of Treating and Preventing Nausea and Vomiting in Patients Receiving Chemotherapy  Journal Articles
• Cost‐effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long‐term model based on the cure trial  Journal Articles
• Design of Effective Health Decision Support Systems: Towards Automating the Health Administrator's Decision Processes  Journal Articles
• Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration  Journal Articles
• Direct and indirect costs incurred by Australian living kidney donors  Journal Articles
• Direct and indirect costs of management of long‐term warfarin therapy in Canada  Journal Articles
• Drug Reimbursement Policies in Canada—Need for Improved Access to Critical Therapies  Journal Articles
• Earlier Initialization of Highly Active Antiretroviral Therapy Is Associated With Long-Term Survival and Is Cost-Effective  Journal Articles
• Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer  Journal Articles
• Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme  Journal Articles
• Economic analysis of epoetin alfa in critically ill trauma patients  Journal Articles
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Journal Articles
• Economic issues in glycoprotein IIb/IIIa receptor therapy  Journal Articles
• Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina with Aggrastat® [tirofiban] and Determine Cost of Therapy with Invasive or Conservative Strategy)–TIMI 18 trial  Journal Articles
• Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty  Journal Articles
• Erectile dysfunction in spinal cord injury: a cost-utility analysis  Journal Articles
• Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.  Journal Articles
• Estimating the clinical cost of drug development for orphan versus non-orphan drugs  Journal Articles
• Evaluating the impact of reference-based pricing.  Journal Articles
• Evaluation of Subcutaneous Rituximab Administration on Canadian Systemic Therapy Suites  Journal Articles
• Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncology.  Journal Articles
• Factor IX pharmacokinetics: differences between plasma‐derived and recombinant products and the clinical and economic implications: a meeting report  Conferences
• Family Physician attitudes about prescribing using a drug formulary  Journal Articles
• GP fundholding and prescribing in UK general practice: evidence from two rural, English Family Health Services Authorities.  Journal Articles
• Global access to affordable direct oral anticoagulants  Journal Articles
• Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non???ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada  Journal Articles
• Haemophilia prophylaxis: how can we justify the costs?  Journal Articles
• Healing an ailing pharmaceutical system: prescription for reform for United States and Canada  Journal Articles
• Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator  Conferences
• Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada  Journal Articles
• Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease  Journal Articles
• Health economics of gastroesophageal reflux disease.  Journal Articles
• Highly Priced Gene Therapies: A Wake-Up Call for Early Price Regulation  Journal Articles
• How do researchers determine the difference to be detected in superiority trials? Results of a survey from a panel of researchers  Journal Articles
• Impact of Cardiac Implantable Electronic Device Infection  Journal Articles
• Impact of a clinical pharmacist in a multidisciplinary intensive care unit  Journal Articles
• Impact of a restrictive drug access program on the risk of cardiovascular encounters in children exposed to ADHD medications.  Journal Articles
• Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.  Journal Articles
• In A Survey, Marked Inconsistency In How Oncologists Judged Value Of High-Cost Cancer Drugs In Relation To Gains In Survival  Journal Articles
• Increased Eligibility for Treatment of Chronic Hepatitis C Infection with Shortened Duration of Therapy: Implications for Access to Care and Elimination Strategies in Canada  Journal Articles
• Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada  Journal Articles
• Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study  Journal Articles
• Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial  Journal Articles
• Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians  Journal Articles
• Management of venous thromboembolism in patients with cancer: role of dalteparin  Journal Articles
• Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study  Journal Articles
• MedsCheck: an opportunity missed  Journal Articles
• Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation  Journal Articles
• Misdiagnosis of bipolar disorder as borderline personality disorder: clinical and economic consequences  Journal Articles
• Modeling Tiered Pricing Frameworks: A Simulation Approach  Journal Articles
• NCDs and the WHO Essential Medicines Lists: children need universal health coverage too  Journal Articles
• Nonulcer dyspepsia and proton pump inhibitors  Journal Articles
• Optimizing the use of prescription drugs in Canada through the Common Drug Review  Journal Articles
• Patient characteristics and costs of severe sepsis and septic shock in Quebec  Journal Articles
• Patients’ Willingness-to-Pay for an Alzheimer’s Disease Medication in Canada  Journal Articles
• Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study  Journal Articles
• Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay  Journal Articles
• Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis  Journal Articles
• Promoting cost effective prescribing  Journal Articles
• Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial  Journal Articles
• Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus  Journal Articles
• Reference-based pricing (RBP) of prescription drugs.  Journal Articles
• Resistance to antibiotics: administrative response to the challenge.  Journal Articles
• Resource Use and costs of End-Of-Life/Palliative Care: Ontario Adult Cancer Patients Dying during 2002 and 2003  Journal Articles
• Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme  Journal Articles
• Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data  Journal Articles
• Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More?  Journal Articles
• Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study  Journal Articles
• Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines  Journal Articles
• Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease  Journal Articles
• Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia  Journal Articles
• The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial  Journal Articles
• The Effect of ICU Sedation Guidelines and Pharmacist Interventions on Clinical Outcomes and Drug Cost  Journal Articles
• The German method for setting ceiling prices for drugs: in some cases less data are required  Journal Articles
• The Impact of Tiered-Pricing Framework on Generic Entry in Canada  Journal Articles
• The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States  Journal Articles
• The Role of Benzodiazepines in the Treatment of Insomnia  Journal Articles
• The burden of illness of osteoporosis in Canada  Journal Articles
• The cost burden of clinically significant esophageal anastomotic leaks—a steep price to pay  Journal Articles
• The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer  Journal Articles
• The effect of patented drug price on the share of new medicines across OECD countries  Journal Articles
• The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada  Journal Articles
• The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis  Journal Articles
• The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study  Journal Articles
• The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada  Journal Articles
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Journal Articles
• The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06.  Journal Articles
• Use of Antidepressants Among Elderly Subjects: Trends and Contributing Factors  Journal Articles
• Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study  Journal Articles
• Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A  Journal Articles
• Valuing Outcomes in Health Care  Journal Articles
• What Is the Economic Value of Digoxin Therapy in Congestive Heart Failure Patients? Results From the DIG Trial  Journal Articles
• When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing  Journal Articles